申请人:TAMBO, INC.
公开号:US11253600B2
公开(公告)日:2022-02-22
Cyclooctene conjugates of therapeutic or diagnostic agents have improved aqueous solubility and can release the agents upon contact with a tetrazine-containing biomaterial. The cyclooctene conjugates provide site-selective delivery of agents at the location of the tetrazine-containing biomaterial in a subject. The compositions and methods have applications in the treatment of various diseases or conditions including cancer, tumor growths, and bacterial infections.
治疗剂或诊断剂的环辛烯共轭物具有更好的水溶性,并能在与含四嗪生物材料接触时释放药剂。环辛烯共轭物可在受试者体内含四氮生物材料的位置选择性地给药。这些组合物和方法可用于治疗各种疾病或病症,包括癌症、肿瘤生长和细菌感染。